Drug Channels

OCTOBER 5, 2021

Click here to download a free report overview (including a summary of industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: Biosimilars Are Delivering Higher Profits for Drug Distributors (press release) We’re offering special discounted pricing if you order before October 15, 2021!

Pharmaceuticals 75

Pharmaceuticals Biosimilars Licensing Licensing 75

Drug Channels

OCTOBER 11, 2022

Click here to download a free report overview (including a summary of industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: U.S. We also update sections that were introduced in recent editions, such as our estimates of wholesalers' profits from provider-administered biosimilar drugs.

Pharmaceuticals 74

Pharmaceuticals Biosimilars Licensing Licensing 74

Drug Channels

APRIL 15, 2025

Whether you're building trust with customers, launching new products, or guiding internal teams, understanding the economic forces that shape drug distribution, reimbursement, and pricing is essential. We also offer licenses to our secure hosted learning environmentno internal setup required! Visit our eLearning page to get started.

Specialty Pharmacies 52

Specialty Pharmacies Pharmaceuticals Pharmacy Licensing 52

Drug Channels

SEPTEMBER 17, 2024

On October 8, 2024, Drug Channels Institute will release our 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. pharmaceutical distribution industry. Read on for more details. All rights reserved.

Pharmaceuticals 52

Pharmaceuticals Licensing Licensing Drugs 52

New Drug Approvals

JUNE 11, 2025

4] This came after the drug had been rejected by the Food and Drug Administration (FDA) three times over two decades due to insufficient evidence of effectiveness. [5] 5] History Gepirone was developed by Bristol-Myers Squibb in 1986, [5] but was out-licensed to Fabre-Kramer in 1993. Food and Drug Administration.

FDA 62

FDA FDA Approval Treatment Clinical Trials 62

Drug Channels

MARCH 18, 2025

I am pleased to announce that Drug Channels Institutes new 2025 Economic Report on U.S. Download a free 30-page report overview including key industry trends, What's New in this edition, the Table of Contents, and a List of Exhibits Read the press release: HMP Globals Drug Channels Institute Releases 2025 Economic Report on U.S.

Pharmacy 52

Pharmacy Specialty Pharmacies Licensing Licensing 52

New Drug Approvals

SEPTEMBER 8, 2024

1] [2] [3] The compound was licensed from Janssen Pharmaceutica NV. [4] 2007.05.007 Drug Discovery, Johnson and Johnson Pharmaceutical Research and Development, LLC, 8 Clarke Drive, Cranbury, NJ 08512, USA Scheme 1. Seladelpar cas 851528-79-5 C 21 H 23 F 3 O 5 S, 444.47 1] It is used as the lysine dihydrate salt. [1] 2007.05.007.

FDA 62

FDA Licensing Licensing FDA Approval 62

FDA Law Blog: Biosimilars

NOVEMBER 1, 2023

Gibbs — For more than three decades, FDA has claimed that the Federal Food, Drug & Cosmetic (FD&C Act) gives the agency legal authority to regulate laboratory developed tests (LDTs) as medical devices (see our prior post here ). Shumsky & Philip Won & Adrienne R. Gaulkin & Jeffrey N.

Laboratories 81

Laboratories FDA Regulations Licensing 81

Drug Target Review

FEBRUARY 28, 2024

These include engineering the cells to express cytokines that promote their maturation and/or differentiation, and engineering drug-resistant γδ T cells that can be combined with chemotherapies, which stress cancer cells but would otherwise also deplete the T-cell population. Kabelitz D, Serrano R, Kouakanou L, et al.

Therapies 105

Therapies Engineering Molecular Biology Science 105

New Drug Approvals

APRIL 25, 2025

12] However, absorption, metabolism, and excretion data of taselisib , a molecule with a related chemical scaffold, suggest moderately slow absorption into the systemic circulation, metabolism to play a minor role in drug clearance, and biliary excretion to be the main route of excretion. [13] 3 November 2006. 3 November 2006.

FDA 57

FDA FDA Approval Therapies Trials 57

The Pharma Data

DECEMBER 16, 2020

OS is a rigorous endpoint that the FDA has recognized as a basis for approval of oncology drugs when a statistically significant improvement can be shown relative to a randomized control arm. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals, Inc.

FDA Approval 52

FDA Approval FDA Pharmaceuticals Clinical Trials 52

Drug Channels

SEPTEMBER 12, 2023

On October 10, 2023, Drug Channels Institute will release 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. If you have any questions before purchasing a license to the report, please email me ( afein@drugchannels.net ). Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmaceuticals 40

Pharmaceuticals Pharmacy Biosimilars Licensing 40

The Pharma Data

OCTOBER 6, 2021

In 2013, Janssen collaborated with Professor Johan Neyts and Suzanne Kaptein at the KU Leuven Rega Institute and Patrick Chaltin at Centre for Drug Design and Discovery (CD3), as well as their respective teams, to identify a compound series capable of inhibiting the virus in lab-grown cells and animals. Janssen Pharmaceutica, N.V.

Virus 52

Virus Clinical Development Science Disease 52

The Pharma Data

OCTOBER 19, 2020

manufacturer, Pharmaceutics International, Inc. (“Pii”), has completed the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (GBM), an aggressive form of brain cancer currently considered incurable. About CNS Pharmaceuticals, Inc.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Treatment 52

The Pharma Data

JANUARY 18, 2021

OKYO has been developing the chemerin molecule as a promising anti-inflammatory treatment for dry-eye disease (“DED”) licensed from researchers at On Target Therapeutics LLC. When Lucentis ® (Ranibizumab) received FDA approval in late June 2006, the new macular degeneration drug was celebrated as a major medical breakthrough.

Science 40

Science Virus Treatment Disease 40

The Pharma Data

NOVEMBER 5, 2020

Prior to that, Taveras was vice president of Small Molecule Drug Discovery and CMC Development at Biogen Idec, and Alantos Pharmaceuticals, which was acquired by Amgen in 2007. Prior to this, he held a position as a director of Analytical Chemistry in Drug Discovery at GlaxoSmithKline. from 1993 to 1995.

Pharmaceuticals 40

Pharmaceuticals Analytical Chemistry Small Molecule Therapies 40

Agency IQ

AUGUST 2, 2024

Happy 40 th Birthday, generic drugs: September 24 will mark the 40 th anniversary of the 1984 signing of the Hatch-Waxman Act, which created a formal pathway for the approval of generic drugs. We expect the FDA to mark the occasion, especially since drug pricing continues to be such a potent issue in the Presidential election.

FDA 40

FDA Science Regulations Biosimilars 40

The Pharma Data

DECEMBER 21, 2020

In September 2018 , the US Food and Drug Administration granted Breakthrough Therapy Designation for tezepelumab in patients with severe asthma, without an eosinophilic phenotype. Amgen develops product candidates internally and through licensing collaborations, partnerships and joint ventures. Respir Med 2006 : 100 (7): 1139-51.

Trials 40

Trials Production Clinical Trials Therapies 40

National Drug & Alcohol Research Centre Blog

NOVEMBER 23, 2023

Ms Daisy Gibbs, Evaluation Officer, Burnet Institute; A/Prof Caitlin Hughes, Associate Professor in Criminology and Drug Policy, Centre for Crime Policy and Research, Flinders University; Dr Rachel Sutherland, Senior Research Fellow, NDARC How long have drug detection dogs been used, why were they introduced, and how common are they?

Drugs 52

Drugs Licensing Licensing Research 52

Drug Channels

FEBRUARY 22, 2022

On March 15, 2022, Drug Channels Institute will release The 2022 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. We also present a more unified outlook for specialty drugs, including specialty generics and biosimilars. Copyright © 2006-2022 Pembroke Consulting, Inc. Click to Enlarge].

Pharmacy 96

Pharmacy Specialty Pharmacies Biosimilars Licensing 96

FDA Law Blog: Biosimilars

AUGUST 29, 2024

That bill, addressing drug (and later biological product) patent settlement agreements (pejoratively referred to as “reverse payment agreements” by their opponents), was first introduced by Senator Herb Kohl (D-WI) in June 2006 as S. But like cockroaches, some pieces of legislation are resilient and never seem to die.

Biosimilars 59

Biosimilars Licensing Licensing Production 59

The Pharma Data

NOVEMBER 22, 2020

In one of the largest heart failure clinical trials ever conducted, our novel mechanism drug candidate demonstrated positive efficacy in a diverse patient population with high unmet need and without an imbalance in the overall incidence of adverse events. SOUTH SAN FRANCISCO, Calif., Conference Call and Webcast Information.

Clinical Trials 52

Clinical Trials Licensing Licensing Trials 52

Drug Channels

OCTOBER 10, 2023

Click here to download a free report overview (including a summary of industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: U.S. we summarize the key provisions of the law that relate to prescription drugs. The exhibits appear in all license versions. d/b/a Drug Channels Institute.

Pharmaceuticals 40

Pharmaceuticals Specialty Pharmacies Pharmacy Biosimilars 40

Drug Channels

OCTOBER 19, 2020

Drug Channels readers will save $300 off the standard rate when they use code GJE973 and register prior to October 30th.*. Drug Channels readers will save $300 off the standard rate when they use code GJE973 and register prior to October 30th.*. Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Science 52

Science Specialty Pharmacies Pharmacy Licensing 52

Drug Channels

OCTOBER 13, 2020

Click here to download a free report overview (including the Table of Contents and a List of Exhibits) New Drug Channels Institute Study Examines Impact of COVID-19 on U.S. Drug Distribution Industry (press release) We’re offering special discounted pricing if you order before October 23, 2020! d/b/a Drug Channels Institute.

Pharmaceuticals 40

Pharmaceuticals Licensing Licensing Pharmacy 40

Agency IQ

JULY 28, 2023

DSCSA implementation – Down to the wire as a deadline draws near: The Drug Supply Chain Security Act (DSCSA) was enacted in 2013 as part of the Drug Quality and Security Act (DQSA), following several drug counterfeiting scandals in which falsified medical products entered the supply chain.

FDA 40

FDA Science Biosimilars Regulations 40

The Pharma Data

JUNE 18, 2021

Food and Drug Administration (FDA) has approved PREVNAR 20 (Pneumococcal 20-valent Conjugate Vaccine) for the prevention of invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes in the vaccine in adults ages 18 years and older. NEW YORK–(BUSINESS WIRE)– Pfizer Inc. 2016;22(1):60.

Vaccine 52

Vaccine FDA Approval FDA Disease 52

Agency IQ

JUNE 16, 2023

Following the EPA’s January 4, 2006, publication of a final rule that revised 40 CFR part 16 to comply with federal mandates associated with the Privacy Act (5 U.S.C. EPA then conducted a residual risk and technology review on July 27, 2006 (71 FR 42724). This action will address Louisiana Environmental Action Network v.

Regulations 40

Regulations Compliance Production Science 40

New Drug Approvals

APRIL 27, 2025

octane-8,1′-azolidin-1-ium]-3-yl 2-hydroxy-2,2-diphenylacetate;chloride FDA 2024, Cobenfy 9/26/2024, To treat schizophrenia Press Release Drug Trials Snapshot Trospium chloride is a muscarinic antagonist used to treat overactive bladder. [3] The drug was excreted somewhat in the milk of nursing mothers. [3] Human M 2 1.1

FDA Approval 57

FDA Approval FDA Pharmacokinetics Licensing 57

New Drug Approvals

MAY 11, 2025

3] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. [9] 3] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. [9] 3] [4] References ^ “Register of Innovative Drugs” Health Canada. 3 November 2006. 3 November 2006.

FDA 57

FDA FDA Approval Disease Production 57

New Drug Approvals

APRIL 18, 2025

in ARKIVOC, 2006, 104 and Tetrahedron Lett., Jump up to: a b “Novel Drug Approvals for 2024” U.S. Food and Drug Administration (FDA). New Drug Therapy Approvals 2024 (PDF). Food and Drug Administration (FDA) (Report). 2005, 46, 7179.In g, 50 mmol) was suspended in ethanol (30 mL). 1 October 2024.

FDA 52

FDA Production FDA Approval Clinical Pharmacology 52

Codon

AUGUST 10, 2023

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Progress in biology is arguably moving faster today than at any point in the course of human history. Drug Discovery Today: Disease Models (2008). Link Production of the antimalarial drug precursor artemisinic acid in engineered yeast , by Ro D-K. Nature (2006).

DNA 98

DNA Cell Biology Molecular Biology Engineering 98

Agency IQ

JULY 12, 2024

A closer look at the seven new proposed regulations Stage of Rulemaking Title Estimated Publication Synopsis Proposed Rule Amendments to the Current Good Manufacturing Practice Regulations for Drug Products February 2025 FDA is proposing to amend the Current Good Manufacturing Practice Regulations for Drug Products.

Regulations 40

Regulations FDA Science Production 40

FDA Law Blog: Biosimilars

DECEMBER 3, 2024

—Each party that violates or assists in the violation of this section shall forfeit and pay to the United States a civil penalty sufficient to deter violations of this section, but in no event greater than 3 times the value received by the party that is reasonably attributable to the violation of this section.

Biosimilars 80

Biosimilars Licensing Licensing Production 80

Codon

AUGUST 10, 2023

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Last edit: 13 September 2023 Progress in biology is arguably moving faster today than at any point in the course of human history. Drug Discovery Today: Disease Models (2008). Link Production of the antimalarial drug precursor artemisinic acid in engineered yeast , by Ro D-K.

DNA 52

DNA Cell Biology Engineering Molecular Biology 52

Codon

FEBRUARY 23, 2025

By Kamal Nahas Scientists had no antiretroviral drugs when the AIDS crisis began in 1981. ” Gilead is already offering the drug at reduced prices in 120 low-income countries with high HIV burdens, including South Africa. By 1987, the FDA licensed zidovudine after trials showed it increased survival rates. million by 2004.

Clinical Trials 80

Clinical Trials Virus Vaccine DNA 80

Drug & Device Law

JULY 31, 2023

2006 WL 2595944, at *23 (N.D. 11, 2006) (same), aff’d in pertinent part , 291 F. 2006) (video game “clearly qualifies as an ‘artistic work’ entitled to First Amendment protection”). 2006), aff’d , 279 F. 18, 2012) (using Black’s Law Dictionary definition of “product” as “tangible personal property”); ABM Industries, Inc.

Production 52

Production Trials International Government 52